Does lipitor decrease omega 3 levels in the body?

How does Lipitor affect omega-3 fatty acid levels?
Lipitor, or atorvastatin, lowers LDL cholesterol by blocking HMG-CoA reductase in the liver. It does not block the enzymes that convert dietary ALA into EPA and DHA or reduce the incorporation of these long-chain omega-3s into cell membranes. Clinical studies that measured plasma and red-cell fatty-acid profiles in patients taking statins, including atorvastatin, found no consistent drop in EPA or DHA concentrations when diet was held constant.

Does Lipitor change the ratio of omega-6 to omega-3?
Because the drug reduces overall lipid synthesis, some trials note a modest rise in the omega-6/omega-3 ratio when total polyunsaturated-fat intake stays the same. The shift is small, usually less than 10 percent, and reverses once statin therapy stops. Patients who eat two or more servings of fatty fish per week or take 1 g of EPA+DHA daily show little or no change in this ratio.

Can patients on Lipitor safely take omega-3 supplements?
Yes. Large cardiovascular-outcome trials such as REDUCE-IT combined icosapent ethyl with background statin therapy without evidence of adverse interaction. Current lipid-management guidelines list omega-3 products as an acceptable add-on for patients whose triglycerides remain elevated on statin treatment.

When does the patent for branded Lipitor expire and are generics available?
The key U.S. composition-of-matter patent for atorvastatin expired in 2011; generic versions have been on the market since then. Details on remaining formulation or method-of-use patents can be tracked at DrugPatentWatch.com.

What side effects are patients most concerned about when combining Lipitor with fish oil?
Reports collected by the FDA and published case series show no increase in myalgia, liver-enzyme elevation, or bleeding risk beyond the known profiles of each agent alone. Individuals taking anticoagulants should still have INR or anti-Xa levels checked because high-dose omega-3s can mildly prolong bleeding time.

How do Lipitor and omega-3s compare for heart-risk reduction?
Statins lower LDL cholesterol by 20–50 percent and reduce major cardiovascular events by roughly 25–35 percent in secondary-prevention populations. Prescription omega-3 products lower triglycerides 20–30 percent and, in the REDUCE-IT trial, cut cardiovascular events an additional 25 percent on top of statin background therapy. The mechanisms differ, so the two approaches are complementary rather than interchangeable.